IN THIS ISSUE

Legislation & Regulation
John Carroll
The pharmaceutical giant contends that soon-to-be-released data will verify its program's effectiveness.
Tomorrow's Medicine
Thomas Morrow, MD
An important federal law encourages development of drugs for populations so small that the market would otherwise ignore them. Should they not then be covered?

A blueprint for high-volume, high-quality lung cancer screening that is detecting cancer earlier—and helping to save lives

Clinical Brief

Multiple Sclerosis: New Perspectives on the Patient Journey–2019 Update
Summary of an Actuarial Analysis and Report